Cellectar Biosciences Inc (CLRB) — Long-term Investment Intensity

Latest as of June 2021: 0.2%

Cellectar Biosciences Inc (CLRB) has a Long-term Investment Intensity of 0.2% as of June 2021. Long-term investments of $75.00K represent 0.2% of total assets of $47.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check CLRB financial resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

$75.00K
USD

Total Assets

$47.74 Million
USD

Country

USA
NASDAQ

Cellectar Biosciences Inc Long-term Investment Intensity (2018–2020)

This chart shows how Cellectar Biosciences Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2018 to 2020. As of June 2021, the intensity stands at 0.2%, reflecting long-term investments of $75.00K against total assets of $47.74 Million USD. For the complete balance sheet picture, see balance sheet size of Cellectar Biosciences Inc.

Annual Long-term Investment Intensity for Cellectar Biosciences Inc (2018–2020)

The table below presents the year-by-year Long-term Investment Intensity for Cellectar Biosciences Inc from 2018 to 2020, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Cellectar Biosciences Inc total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2020 0.1% $75.00K $58.66 Million ▼ -0.5 pp
2019 0.6% $75.00K $12.25 Million ▼ -3.0 pp
2018 3.6% $540.82K $15.05 Million
pp = percentage points